AIS
REGN icon

Accurate Investment Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Accurate Investment Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-125
Closed -$61K – 299
2020
Q1 		$61K Hold
125
– – 0.05% 180
2019
Q4 		$47K Buy
125
+25
+25% +$8.41K 0.03% 179
2019
Q3 		$28K Hold
100
– – 0.02% 151
2019
Q2 		$31K Buy
+100
New +$33.3K 0.02% 142

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Accurate Investment Solutions's REGN Position: Q2 2020 in Review

Accurate Investment Solutions sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 125 shares — an estimated $61K sold.

Accurate Investment Solutions first reported a position in REGN in Q2 2019 and held it in 4 quarters. The position peaked at $61K in Q1 2020. 932 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Accurate Investment Solutions reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Accurate Investment Solutions sold 125 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $61K.
  • Accurate Investment Solutions first reported a position in Regeneron Pharmaceuticals in Q2 2019 and held it in 4 quarters.
  • Accurate Investment Solutions's Regeneron Pharmaceuticals position peaked at $61K in Q1 2020.
  • 932 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.